Literature DB >> 19124781

The controversy over the efficacy of pneumococcal vaccine.

Ross Andrews1, Sarah A Moberley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19124781      PMCID： PMC2612055          DOI： 10.1503/cmaj.081744

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  23-valent pneumococcal polysaccharide vaccine. WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2008-10-17

2.  Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study.

Authors:  P KAUFMAN
Journal:  Arch Intern Med (Chic)       Date:  1947-05

3.  Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Authors:  Catherine A Lexau; Ruth Lynfield; Richard Danila; Tamara Pilishvili; Richard Facklam; Monica M Farley; Lee H Harrison; William Schaffner; Arthur Reingold; Nancy M Bennett; James Hadler; Paul R Cieslak; Cynthia G Whitney
Journal:  JAMA       Date:  2005-10-26       Impact factor: 56.272

4.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.

Authors:  P O Honkanen; T Keistinen; L Miettinen; E Herva; U Sankilampi; E Läärä; M Leinonen; S L Kivelä; P H Mäkelä
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

5.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

6.  Efficacy of pneumococcal vaccination in adults: a meta-analysis.

Authors:  Anke Huss; Pippa Scott; Andreas E Stuck; Caroline Trotter; Matthias Egger
Journal:  CMAJ       Date:  2009-01-06       Impact factor: 8.262

7.  Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community.

Authors:  I D Riley; P I Tarr; M Andrews; M Pfeiffer; R Howard; P Challands; G Jennison
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

Review 8.  Vaccines for preventing pneumococcal infection in adults.

Authors:  S A Moberley; J Holden; D P Tatham; R M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  8 in total
  2 in total

1.  Efficacy of pneumococcal polysaccharide vaccine.

Authors:  Pippa Scott; Anke Huss; Andreas E Stuck; Caroline Trotter; Matthias Egger
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

2.  Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.

Authors:  Satoshi Inoue; Yuji Watanuki; Tetsuji Kaneko; Takashi Sato; Naoki Miyazawa; Takeshi Kaneko; Yoshiaki Ishigatsubo; Satoshi Morita; Yutaka Natsumeda; Shunsaku Mizushima
Journal:  BMJ Open       Date:  2011-07-18       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.